Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crump

Showing results (61-70 of 183) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|June 3, 2020
Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphomaCatherine Tang, Osvaldo Espin-Garcia, Anca Prica, et al.
Leukemia & Lymphoma|April 25, 2007
Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop CriteriaSarit Assouline, Ralph M Meyer, Claire Infante-Rivard, et al.
Blood|October 22, 2008
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemiaSusan M O'Brien, David F Claxton, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcomeRichard W Tsang, Mary K Gospodarowicz, Melania Pintilie, et al.
Leukemia & Lymphoma|October 29, 2002
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group studyMichael Crump, Stephen Couban, Ralph Meyer, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphomaChandra Martens, David C Hodgson, Woodrow A Wells, et al.
Blood|July 3, 2010
A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart diseaseSten Myrehaug, Melania Pintilie, Lingsong Yun, et al.
Pathology, Research and Practice|August 29, 2021
Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature reviewSarah Morgan, Rosemarie Tremblay-LeMay, Joan E Lipa, et al.
Leukemia & Lymphoma|November 13, 2025
Real-world outcomes in adult histiocytosis: the uncharted territory of orphan diseasesRintu Sharma, Alfredo de la Torre, Umberto Falcone, et al.
Leukemia & Lymphoma|July 10, 2024
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trialAbi Vijenthira, Xinzhi Li, Michael Crump, et al.
Pageof 19

Showing results (61-70 of 183) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|June 3, 2020
Efficacy and safety of stem cell mobilization following gemcitabine, dexamethasone, cisplatin (GDP) salvage chemotherapy in patients with relapsed or refractory lymphomaCatherine Tang, Osvaldo Espin-Garcia, Anca Prica, et al.
Leukemia & Lymphoma|April 25, 2007
Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop CriteriaSarit Assouline, Ralph M Meyer, Claire Infante-Rivard, et al.
Blood|October 22, 2008
Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemiaSusan M O'Brien, David F Claxton, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcomeRichard W Tsang, Mary K Gospodarowicz, Melania Pintilie, et al.
Leukemia & Lymphoma|October 29, 2002
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group studyMichael Crump, Stephen Couban, Ralph Meyer, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2005
Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphomaChandra Martens, David C Hodgson, Woodrow A Wells, et al.
Blood|July 3, 2010
A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart diseaseSten Myrehaug, Melania Pintilie, Lingsong Yun, et al.
Pathology, Research and Practice|August 29, 2021
Breast implant-associated EBV-positive diffuse large B-cell lymphoma: Two case reports and literature reviewSarah Morgan, Rosemarie Tremblay-LeMay, Joan E Lipa, et al.
Leukemia & Lymphoma|November 13, 2025
Real-world outcomes in adult histiocytosis: the uncharted territory of orphan diseasesRintu Sharma, Alfredo de la Torre, Umberto Falcone, et al.
Leukemia & Lymphoma|July 10, 2024
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trialAbi Vijenthira, Xinzhi Li, Michael Crump, et al.
Pageof 19